Synergy Pharmaceuticals Appoints Gary G. Gemignani as Chief Financial Officer


Pharmaceuticals Inc. today announced that Gary G. Gemignani has been appointed as Executive Vice President and Chief Financial Officer, effective April 17, 2017. Mr. Gemignani replaces Senior Vice President, Finance, Bernard Denoyer, who will assist in the transition process until his retirement on July 1, 2017.



from Biotech News